These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 22313897)

  • 1. Review of vasopressor therapy in the setting of vasodilatory shock.
    Bockenstedt TL; Baker SN; Weant KA; Mason MA
    Adv Emerg Nurs J; 2012; 34(1):16-23. PubMed ID: 22313897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Arginine vasopressin in vasodilatory shock: a new therapy approach?].
    Dünser M; Wenzel V; Mayr AJ; Hasibeder WR
    Anaesthesist; 2002 Aug; 51(8):650-9; discussion 659-60. PubMed ID: 12391525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review article: inotrope and vasopressor use in the emergency department.
    Senz A; Nunnink L
    Emerg Med Australas; 2009 Oct; 21(5):342-51. PubMed ID: 19694785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of vasodilatory shock: defining the role of arginine vasopressin.
    Dunser MW; Wenzel V; Mayr AJ; Hasibeder WR
    Drugs; 2003; 63(3):237-56. PubMed ID: 12534330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Before-after study of a standardized hospital order set for the management of septic shock.
    Micek ST; Roubinian N; Heuring T; Bode M; Williams J; Harrison C; Murphy T; Prentice D; Ruoff BE; Kollef MH
    Crit Care Med; 2006 Nov; 34(11):2707-13. PubMed ID: 16943733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacologic Agents for the Treatment of Vasodilatory Shock.
    Knotzer H; Poidinger B; Kleinsasser A
    Curr Pharm Des; 2019; 25(19):2133-2139. PubMed ID: 31272348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of vasopressors and inotropes in the emergency medical treatment of shock.
    Ellender TJ; Skinner JC
    Emerg Med Clin North Am; 2008 Aug; 26(3):759-86, ix. PubMed ID: 18655944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation and management of shock States: hypovolemic, distributive, and cardiogenic shock.
    Moranville MP; Mieure KD; Santayana EM
    J Pharm Pract; 2011 Feb; 24(1):44-60. PubMed ID: 21507874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding vasoactive medications: focus on pharmacology and effective titration.
    Allen JM
    J Infus Nurs; 2014; 37(2):82-6. PubMed ID: 24583937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Septic shock.
    Baxter F
    Can J Anaesth; 1997 Jan; 44(1):59-72. PubMed ID: 8988826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Vasopressor Support Sparing Strategies": a Concept to be Incorporated as a Paradigm in the Treatment of Vasodilatory Shock.
    Evora PRB; Braile DM
    Braz J Cardiovasc Surg; 2019; 34(1):I-II. PubMed ID: 30810668
    [No Abstract]   [Full Text] [Related]  

  • 12. [Shock therapy: Which catecholamine is the best?].
    Werdan K
    Dtsch Med Wochenschr; 2011 Nov; 136(45):2292. PubMed ID: 22052588
    [No Abstract]   [Full Text] [Related]  

  • 13. Neonatal blood pressure support: the use of inotropes, lusitropes, and other vasopressor agents.
    Noori S; Seri I
    Clin Perinatol; 2012 Mar; 39(1):221-38. PubMed ID: 22341548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of vasopressin in the treatment of vasodilation in shock states.
    Rozenfeld V; Cheng JW
    Ann Pharmacother; 2000 Feb; 34(2):250-4. PubMed ID: 10676834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasopressor agents in shock.
    Moyer JH; Mills LC
    Am J Nurs; 1975 Apr; 75(4):620-5. PubMed ID: 1039254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study.
    Dünser MW; Mayr AJ; Ulmer H; Knotzer H; Sumann G; Pajk W; Friesenecker B; Hasibeder WR
    Circulation; 2003 May; 107(18):2313-9. PubMed ID: 12732600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of angiotensin II as vasopressor in vasodilatory shock.
    Lumlertgul N; Ostermann M
    Future Cardiol; 2020 Nov; 16(6):569-583. PubMed ID: 32462921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-2 agonists to reduce vasopressor requirements in septic shock?
    Pichot C; Géloën A; Ghignone M; Quintin L
    Med Hypotheses; 2010 Dec; 75(6):652-6. PubMed ID: 20817367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasopressin in catecholamine-refractory shock in children.
    Meyer S; Gortner L; McGuire W; Baghai A; Gottschling S
    Anaesthesia; 2008 Mar; 63(3):228-34. PubMed ID: 18081903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of Refractory Vasodilatory Shock.
    Jentzer JC; Vallabhajosyula S; Khanna AK; Chawla LS; Busse LW; Kashani KB
    Chest; 2018 Aug; 154(2):416-426. PubMed ID: 29329694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.